Trevena

Based in the United States, Trevena is a startup. Brouky classifies it under Healthcare & Life Sciences.

Trevena, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders, including FDA-approved acute pain treatment OLINVYK® and investigational drugs for diabetic neuropathic pain, epilepsy, migraine, and opioid use disorder.